Figure 6.
FXIIIplasmainfusion into F13a−/−mice rescues thrombus weight.F13a+/+, F13a+/−, and F13a−/− mice infused with vehicle and F13a−/− mice infused with FXIII-A2B2 were subjected to the IVC venous thrombosis model. (A) Thrombi were harvested after 24 hours and weighed. Each dot represents a separate mouse. (B) Correlation between FXIII-A level in plasma (measured by western blot and densitometry, shown as relative band intensity, arbitrary fluorescence units) and thrombus weights for F13a+/+, F13a+/−, F13a−/− (from panel A), and FXIII-A2B2-infused mice. Each dot represents a separate mouse; F13a+/+ (green closed circles), F13a+/− (blue half circles), F13a−/− (red open circles) mice, and FXIII-A2B2-infused F13a−/− mice targeting 100% (green triangles), 50% (blue triangles), 25% (pink triangles), and 10% (orange triangles) FXIII-A2B2. (C) Representative western blots showing FXIII-A in plasma immediately after infusion of 50% FXIII-A2B2 (plasma final, top), and in plasma (middle) and platelets (bottom) 24 hours after infusion and ligation. Note that infused human FXIII-A2B2 is more strongly detected than mouse.

FXIIIplasmainfusion into F13a−/−mice rescues thrombus weight.F13a+/+, F13a+/−, and F13a−/− mice infused with vehicle and F13a−/− mice infused with FXIII-A2B2 were subjected to the IVC venous thrombosis model. (A) Thrombi were harvested after 24 hours and weighed. Each dot represents a separate mouse. (B) Correlation between FXIII-A level in plasma (measured by western blot and densitometry, shown as relative band intensity, arbitrary fluorescence units) and thrombus weights for F13a+/+, F13a+/−, F13a−/− (from panel A), and FXIII-A2B2-infused mice. Each dot represents a separate mouse; F13a+/+ (green closed circles), F13a+/− (blue half circles), F13a−/− (red open circles) mice, and FXIII-A2B2-infused F13a−/− mice targeting 100% (green triangles), 50% (blue triangles), 25% (pink triangles), and 10% (orange triangles) FXIII-A2B2. (C) Representative western blots showing FXIII-A in plasma immediately after infusion of 50% FXIII-A2B2 (plasma final, top), and in plasma (middle) and platelets (bottom) 24 hours after infusion and ligation. Note that infused human FXIII-A2B2 is more strongly detected than mouse.

Close Modal

or Create an Account

Close Modal
Close Modal